U.S. Physical Therapy, Inc. (USPH): Price and Financial Metrics
U.S. Physical Therapy, Inc. (USPH)
Today's Latest Price: $131.59 USD
Updated Jan 22 6:40pm
Add USPH to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 77 in Medical - Services
See all "A" rated Strong Buy stocks
USPH Stock Summary
- With a price/earnings ratio of 56.19, U S Physical Therapy Inc P/E ratio is greater than that of about 80.49% of stocks in our set with positive earnings.
- Of note is the ratio of U S Physical Therapy Inc's sales and general administrative expense to its total operating expenses; 88.08% of US stocks have a lower such ratio.
- With a year-over-year growth in debt of -29.18%, U S Physical Therapy Inc's debt growth rate surpasses merely 10.8% of about US stocks.
- Stocks that are quantitatively similar to USPH, based on their financial statements, market capitalization, and price volatility, are PLXS, MC, WNS, RYB, and HMSY.
- Visit USPH's SEC page to see the company's official filings. To visit the company's web site, go to www.usph.com.
USPH Stock Price Chart Interactive Chart >
USPH Price/Volume Stats
| Current price | $131.59 | 52-week high | $134.11 |
| Prev. close | $127.49 | 52-week low | $45.13 |
| Day low | $125.98 | Volume | 51,000 |
| Day high | $131.67 | Avg. volume | 59,357 |
| 50-day MA | $116.81 | Dividend yield | 0.24% |
| 200-day MA | $90.22 | Market Cap | 1.69B |
U.S. Physical Therapy, Inc. (USPH) Company Bio
U.S. Physical Therapy operates clinics which provide preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurologically-related injuries and rehabilitation of injured workers. The company was founded in 1990 and is based in Houston, Texas.
USPH Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $131.59 | $93.21 | -29% |
Below please find a table outlining a discounted cash flow forecast for USPH, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that U S Physical Therapy Inc ranked in the 44th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of U S Physical Therapy Inc, consider:
- The company's debt burden, as measured by earnings divided by interest payments, is 21.61 -- which is good for besting 84.35% of its peer stocks (US stocks in the Healthcare sector with positive cash flow).
- The business' balance sheet reveals debt to be 6% of the company's capital (with equity being the remaining amount). Approximately just 18.12% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
- USPH's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 42.13% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -31% |
| 1% | -30% |
| 2% | -29% |
| 3% | -28% |
| 4% | -28% |
| 5% | -27% |
ADUS, AMGN, INBP, STE, and NVS can be thought of as valuation peers to USPH, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...